Evaluation at 5 and 10 Years of Renal Transplant Patients
Launched by UNIVERSITY HOSPITAL, BREST · Jul 21, 2022
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at kidney transplant patients who have been part of a previous study called the OXYOP study. The goal is to follow these patients for 5 and 10 years to learn more about their health, any complications they might face, and how well their transplants are working over time. The study will include patients aged between 65 and 74 years who have already completed a follow-up visit in the OXYOP study and agree to participate in this new observational study.
To be eligible, patients must be willing to share their medical information and cannot have lost their kidney transplant or passed away before the 48-month mark. It's important for potential participants to know that this study is not yet recruiting, meaning they cannot sign up just yet. Those who do participate can expect to contribute to ongoing research that may help improve care for future kidney transplant patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • informed patients participating to the oxyop study
- • Patient having completed the OXYOP M12 follow-up visit
- • Patient agreeing to participate in the observational study
- Exclusion Criteria:
- • Opposition to the use his medical data
- • patient deceased or with graft lost before M48
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, , France
Patients applied
Trial Officials
Yannick Le Meur
Principal Investigator
University hospital Brest France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials